Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved ... According to Chinese business news website Yicai, a dose of four Wegovy injections will cost 1,400 yuan (£153; $194), a fraction of the drug's price in the United ...

Novo Nordisk launches its weight-loss drug Wegovy in China after approval by local health authorities in June.

Though these drugs were originally developed for managing blood sugar in people with type 2 diabetes, researchers soon realized that people taking these drugs were also losing a considerable amount of weight. Studies show that Ozempic and Wegovy users can achieve reductions of 10–15 per cent of their body weight.

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest dose.

Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles high rates of obesity.A Novo Nordisk spokesperson confirmed to AFP on Tuesday that the drug was "now available in China" for the treatment of adults with obesity and those overweight with at least one weight-related comorbidity.

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Novo Nordisk has officially launched its weight-loss drug Wegovy in China after receiving approval in June. The move pits it against rival Eli Lilly, whose treatment, Zepbound, is yet to hit shelves in the world's second-largest pharmaceutical market.